Pharmacopeia, Inc.

Pharmacopeia was a public biotechnology company that pioneered the field of small molecule combinatorial chemistry.

Pharmacopeia was founded by Larry Bock and Drs. Michael Wigler, Clark Still and Jack Chabala.

Pharmacopeia went public in 1996 and was acquired by Ligand Pharmaceuticals on December 13, 2008.

References
      • Historical business data for Pharmacopeia, Inc.:
      • SEC filings
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.